Literature DB >> 19946325

Role of oxidants/inflammation in declining renal function in chronic kidney disease and normal aging.

Helen Vlassara1, Massimo Torreggiani, James B Post, Feng Zheng, Jaime Uribarri, Gary E Striker.   

Abstract

Oxidant stress (OS) and inflammation increase in normal aging and in chronic kidney disease (CKD), as observed in human and animal studies. In cross-sectional studies of the US population, these changes are associated with a decrease in renal function, which is exhibited by a significant proportion of the population. However, since many normal adults have intact renal function, and longitudinal studies show that some persons maintain normal renal function with age, the link between OS, inflammation, and renal decline is not clear. In aging mice, greater oxidant intake is associated with increased age-related CKD and mortality, which suggests that interventions that reduce OS and inflammation may be beneficial for older individuals. Both OS and inflammation can be readily lowered in normal subjects and patients with CKD stage 3-4 by a simple dietary modification that lowers intake and results in reduced serum and tissue levels of advanced glycation end products. Diabetic patients, including those with microalbuminuria, have a decreased ability to metabolize and excrete oxidants prior to observable changes in serum creatinine. Thus, OS and inflammation may occur in the diabetic kidney at an early time. We review the evidence that oxidants in the diet directly lead to increased serum levels of OS and inflammatory mediators in normal aging and in CKD. We also discuss a simple dietary intervention that helps reduce OS and inflammation, an important and achievable therapeutic goal for patients with CKD and aging individuals with reduced renal function.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19946325     DOI: 10.1038/ki.2009.401

Source DB:  PubMed          Journal:  Kidney Int Suppl        ISSN: 0098-6577            Impact factor:   10.545


  51 in total

1.  The effects of anti-inflammatory and anti-angiogenic DNA vaccination on diabetic nephropathy in rats.

Authors:  Peter Celec; Július Hodosy; Roman Gardlík; Michal Behuliak; Roland Pálffy; Marek Pribula; Peter Jáni; Ján Turňa; Katarína Sebeková
Journal:  Hum Gene Ther       Date:  2012-01-26       Impact factor: 5.695

2.  Connections in chronic kidney disease: connexin 43 and connexin 37 interaction.

Authors:  Pedro A Jose; Shiyou Chen; Ines Armando
Journal:  Am J Physiol Renal Physiol       Date:  2011-04-27

3.  Aging is associated with hypoxia and oxidative stress in adipose tissue: implications for adipose function.

Authors:  Le Zhang; Philip J Ebenezer; Kalavathi Dasuri; Sun Ok Fernandez-Kim; Joseph Francis; Nithya Mariappan; Zhanguo Gao; Jianping Ye; Annadora J Bruce-Keller; Jeffrey N Keller
Journal:  Am J Physiol Endocrinol Metab       Date:  2011-05-17       Impact factor: 4.310

Review 4.  The systemic nature of CKD.

Authors:  Carmine Zoccali; Raymond Vanholder; Ziad A Massy; Alberto Ortiz; Pantelis Sarafidis; Friedo W Dekker; Danilo Fliser; Denis Fouque; Gunnar H Heine; Kitty J Jager; Mehmet Kanbay; Francesca Mallamaci; Gianfranco Parati; Patrick Rossignol; Andrzej Wiecek; Gerard London
Journal:  Nat Rev Nephrol       Date:  2017-04-24       Impact factor: 28.314

5.  Nutritional Interventions that Slow the Age-Associated Decline in Renal Function in a Canine Geriatric Model for Elderly Humans.

Authors:  J A Hall; M Yerramilli; E Obare; M Yerramilli; K S Panickar; G Bobe; D E Jewell
Journal:  J Nutr Health Aging       Date:  2016       Impact factor: 4.075

Review 6.  AGE restriction in diabetes mellitus: a paradigm shift.

Authors:  Helen Vlassara; Gary E Striker
Journal:  Nat Rev Endocrinol       Date:  2011-05-24       Impact factor: 43.330

7.  Estrogen receptor subtype ratio change protects against podocyte damage.

Authors:  Paola Catanuto; Xiaomei Xia; Simone Pereira-Simon; Sharon Elliot
Journal:  Curr Trends Endocinol       Date:  2017

Review 8.  Advanced glycation end products (AGE) and diabetes: cause, effect, or both?

Authors:  Helen Vlassara; Jaime Uribarri
Journal:  Curr Diab Rep       Date:  2014-01       Impact factor: 4.810

9.  Rhein lysinate increases the median survival time of SAMP10 mice: protective role in the kidney.

Authors:  Gang Hu; Jiang Liu; Yong-zhan Zhen; Rong Xu; Yu Qiao; Jie Wei; Ping Tu; Ya-jun Lin
Journal:  Acta Pharmacol Sin       Date:  2013-03-11       Impact factor: 6.150

10.  Kidney function decline in metformin versus sulfonylurea initiators: assessment of time-dependent contribution of weight, blood pressure, and glycemic control.

Authors:  Adriana M Hung; Christianne L Roumie; Robert A Greevy; Xulei Liu; Carlos G Grijalva; Harvey J Murff; Marie R Griffin
Journal:  Pharmacoepidemiol Drug Saf       Date:  2013-06       Impact factor: 2.890

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.